rofecoxib has been researched along with Prostatic Neoplasms in 9 studies
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with celecoxib also led to dose-dependent inhibition of PC3 xenograft growth without causing a reduction in intratumor prostaglandin E(2)." | 1.33 | Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. ( Chang, M; Cordon-Cardo, C; Dannenberg, AJ; Du, B; Newman, RA; Patel, MI; Subbaramaiah, K; Thaler, HT; Yang, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pommery, N | 1 |
| Taverne, T | 1 |
| Telliez, A | 1 |
| Goossens, L | 1 |
| Charlier, C | 1 |
| Pommery, J | 1 |
| Goossens, JF | 1 |
| Houssin, R | 1 |
| Durant, F | 1 |
| Hénichart, JP | 1 |
| Liu, GZ | 1 |
| Xu, HW | 1 |
| Wang, P | 1 |
| Lin, ZT | 1 |
| Duan, YC | 1 |
| Zheng, JX | 1 |
| Liu, HM | 1 |
| Walter, B | 1 |
| Rogenhofer, S | 1 |
| Vogelhuber, M | 1 |
| Berand, A | 1 |
| Wieland, WF | 1 |
| Andreesen, R | 1 |
| Reichle, A | 1 |
| Zhu, J | 1 |
| Song, X | 3 |
| Lin, HP | 2 |
| Young, DC | 1 |
| Yan, S | 1 |
| Marquez, VE | 1 |
| Chen, CS | 2 |
| Patel, MI | 1 |
| Subbaramaiah, K | 1 |
| Du, B | 1 |
| Chang, M | 1 |
| Yang, P | 1 |
| Newman, RA | 1 |
| Cordon-Cardo, C | 1 |
| Thaler, HT | 1 |
| Dannenberg, AJ | 1 |
| van Adelsberg, J | 1 |
| Gann, P | 1 |
| Ko, AT | 1 |
| Damber, JE | 1 |
| Logothetis, C | 1 |
| Marberger, M | 1 |
| Schmitz-Drager, BJ | 1 |
| Tubaro, A | 1 |
| Harms, CJ | 1 |
| Roehrborn, C | 1 |
| Johnson, AJ | 2 |
| Hsu, A | 1 |
| Chen, C | 1 |
| Tseng, PH | 1 |
| Yang, YT | 1 |
| Kulp, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Rofecoxib in Decreasing the Risk of Prostate Cancer (ViP Study)[NCT00060476] | Phase 3 | 15,000 participants (Actual) | Interventional | 2003-01-08 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for rofecoxib and Prostatic Neoplasms
| Article | Year |
|---|---|
Modular therapy approach in metastatic castration-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Capecitabine; Deoxycytidine; Dexamet | 2010 |
The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.
Topics: Adult; Aged; Aged, 80 and over; Cyclooxygenase Inhibitors; Double-Blind Method; Humans; Lactones; Ma | 2007 |
7 other studies available for rofecoxib and Prostatic Neoplasms
| Article | Year |
|---|---|
New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Proli | 2004 |
Stereoselective synthesis and anti-proliferative effects on prostate cancer evaluation of 5-substituted-3,4-diphenylfuran-2-ones.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxyge | 2013 |
Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Cele | 2002 |
Top 10 health stories of 2004.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antidepressive Agents; Antineopla | 2004 |
Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
Topics: Animals; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenas | 2005 |
Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells.
Topics: Apoptosis; Calcium; Celecoxib; Cell Cycle; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibit | 2001 |
Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 I | 2002 |